SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-21-009808
Filing Date
2021-10-06
Accepted
2021-10-06 17:03:35
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES mdesai-form4_100121.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES mdesai-form4_100121.xml 4 4402
  Complete submission text file 0001387131-21-009808.txt   5940
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1682 EL CAMINO REAL STE 300 SAN DIEGO CA 92130
Business Address
Desai Meera J. (Reporting) CIK: 0001886559 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 211310328